Fungal biofilm: a relentless barrier to the cure of vulvovaginal candidiasis in post-radiotherapy cervical cancer patients
DOI:
https://doi.org/10.5327/2237-4574-2024810013Keywords:
candidiasis, Papanicolaou test, biofilmsAbstract
Persistent candidiasis is a challenge for gynecological clinics, especially when associated with non-albicans Candida, as it is resistant to routine treatments. The formation of fungal biofilms recently described for those microorganisms greatly prevents the action of antimicrobials, accentuating the maintenance of a resistant microenvironment. The radiation effect decreases local defense mechanisms in patients treated for cervical cancer with radiotherapy, which enhances the pathogenicity and infection persistence. Persistent forms of blastoconidia suggestive of non-albicans forms should be reported on the Pap test. Even though the method presents low sensitivity and specificity for confirming microorganisms, the persistent condition can be referred, as it was related in our case, warning clinicians to apply vigorous therapy, especially in hospital environments and cancer centers, preventing the formation of fungal biofilms.
References
Nayar R, Wilbur DC. The Bethesda system for reporting cervical cytology. Definitions, criteria and explanatory notes. 3rd ed. New York: Springer; 2015. https://doi.org/10.1007/978-3-319-11074-5
Souza AC, Paula CR, Ruiz LS, Margarido PFR, Auler ME, Lorenzi NPC, et al. Relation between Candida species isolated from vaginal mucosa and lesions caused by high-risk Human Papillomavirus HPV for cervical cancer. Rev Patol Trop. 2021;50(3):212-22. https://doi.org/10.5216/rpt.v50i3.66032
Reithofer V, Fernández-Pereira J, Alvarado M, Groot P, Essen LO. A novel class of Candida glabrata cell wall proteins with β-helix fold mediates adhesion in clinical isolates. PLoS Pathog. 2021;17(12):e1009980. https://doi.org/10.1371/journal.ppat.1009980